|
HUE029744T2
(en)
*
|
2007-07-26 |
2017-04-28 |
Uniqure Ip Bv |
Baculoviral vectors comprising repeated coding sequences with differential codon biases
|
|
GB0911870D0
(en)
|
2009-07-08 |
2009-08-19 |
Ucl Business Plc |
Optimised coding sequence and promoter
|
|
EP2545165B1
(en)
|
2010-03-11 |
2020-07-29 |
uniQure IP B.V. |
Mutated rep encoding sequences for use in aav production
|
|
WO2011122950A1
(en)
|
2010-04-01 |
2011-10-06 |
Amsterdam Molecular Therapeutics (Amt) Ip B.V. |
Monomeric duplex aav vectors
|
|
IT1400425B1
(it)
|
2010-06-08 |
2013-05-31 |
Amsterdam Molecular Therapeutics Bv |
Modified snrnas for use in therapy.
|
|
US20140155469A1
(en)
*
|
2011-04-19 |
2014-06-05 |
The Research Foundation Of State University Of New York |
Adeno-associated-virus rep sequences, vectors and viruses
|
|
GB201210357D0
(en)
|
2012-06-12 |
2012-07-25 |
Ucl Business Plc |
Factor VIII sequences
|
|
WO2015060722A1
(en)
|
2013-10-24 |
2015-04-30 |
Uniqure Ip B.V. |
Aav-5 pseudotyped vector for gene therapy for neurological diseases
|
|
WO2015137802A1
(en)
*
|
2014-03-10 |
2015-09-17 |
Uniqure Ip B.V. |
Further improved aav vectors produced in insect cells
|
|
US10577627B2
(en)
|
2014-06-09 |
2020-03-03 |
Voyager Therapeutics, Inc. |
Chimeric capsids
|
|
EP3215191B1
(en)
|
2014-11-05 |
2024-08-14 |
Voyager Therapeutics, Inc. |
Aadc polynucleotides for the treatment of parkinson's disease
|
|
GB201420139D0
(en)
|
2014-11-12 |
2014-12-24 |
Ucl Business Plc |
Factor IX gene therapy
|
|
CN114717264A
(zh)
|
2014-11-14 |
2022-07-08 |
沃雅戈治疗公司 |
治疗肌萎缩性侧索硬化(als)的组合物和方法
|
|
KR20230145206A
(ko)
|
2014-11-14 |
2023-10-17 |
보이저 테라퓨틱스, 인크. |
조절성 폴리뉴클레오티드
|
|
HUE046643T2
(hu)
|
2014-11-28 |
2021-11-29 |
Uniqure Ip Bv |
DNS szennyezõdések parvovirális virionokat tartalmazó készítményben
|
|
US11697825B2
(en)
|
2014-12-12 |
2023-07-11 |
Voyager Therapeutics, Inc. |
Compositions and methods for the production of scAAV
|
|
AU2015370903B2
(en)
|
2014-12-24 |
2021-06-17 |
Uniqure Ip B.V. |
RNAi induced huntingtin gene suppression
|
|
CA3012699C
(en)
|
2016-04-21 |
2023-11-21 |
Virovek, Inc |
Aav production in insect cells, methods and compositions therefor
|
|
EP3448987A4
(en)
|
2016-04-29 |
2020-05-27 |
Voyager Therapeutics, Inc. |
COMPOSITIONS FOR TREATING A DISEASE
|
|
EP3448874A4
(en)
|
2016-04-29 |
2020-04-22 |
Voyager Therapeutics, Inc. |
COMPOSITIONS FOR TREATING A DISEASE
|
|
US10584337B2
(en)
|
2016-05-18 |
2020-03-10 |
Voyager Therapeutics, Inc. |
Modulatory polynucleotides
|
|
IL297576B2
(en)
|
2016-05-18 |
2024-02-01 |
Voyager Therapeutics Inc |
Compositions and methods of treating huntington's disease
|
|
JP6994018B2
(ja)
*
|
2016-07-26 |
2022-01-14 |
バイオマリン ファーマシューティカル インコーポレイテッド |
新規アデノ随伴ウイルスキャプシドタンパク質
|
|
WO2018039375A1
(en)
|
2016-08-23 |
2018-03-01 |
Akouos, Inc. |
Compositions and methods for treating non-age-associated hearing impairment in a human subject
|
|
EP3831281B1
(en)
|
2016-08-30 |
2026-02-25 |
The Regents of The University of California |
Devices and systems for biomedical targeting and delivery
|
|
CA3045551A1
(en)
|
2016-12-16 |
2018-06-21 |
Uniqure Ip B.V. |
Immunoadsorption
|
|
EP3618839A4
(en)
|
2017-05-05 |
2021-06-09 |
Voyager Therapeutics, Inc. |
COMPOSITIONS AND METHODS OF TREATMENT OF AMYOTROPHIC LATERAL SCLEROSIS (ALS)
|
|
MX2019013172A
(es)
|
2017-05-05 |
2020-09-07 |
Voyager Therapeutics Inc |
Composiciones y metodos para tratar la enfermedad de huntington.
|
|
JOP20190269A1
(ar)
|
2017-06-15 |
2019-11-20 |
Voyager Therapeutics Inc |
بولي نوكليوتيدات aadc لعلاج مرض باركنسون
|
|
US11452749B2
(en)
|
2017-07-10 |
2022-09-27 |
Uniqure Ip B.V. |
Means and methods for AAV gene therapy in humans
|
|
CA3070087A1
(en)
|
2017-07-17 |
2019-01-24 |
Voyager Therapeutics, Inc. |
Trajectory array guide system
|
|
US11512327B2
(en)
|
2017-08-03 |
2022-11-29 |
Voyager Therapeutics, Inc. |
Compositions and methods for delivery of AAV
|
|
MX2020003042A
(es)
|
2017-09-29 |
2020-11-18 |
Voyager Therapeutics Inc |
Rescate del fenotipo neurológico central y periférico de la ataxia de friedreich mediante administración intravenosa.
|
|
WO2019079242A1
(en)
|
2017-10-16 |
2019-04-25 |
Voyager Therapeutics, Inc. |
TREATMENT OF AMYOTROPHIC LATERAL SCLEROSIS (ALS)
|
|
TW202413649A
(zh)
|
2017-10-16 |
2024-04-01 |
美商航海家醫療公司 |
肌萎縮性脊髓側索硬化症(als)之治療
|
|
CN111527201A
(zh)
|
2017-12-29 |
2020-08-11 |
优尼科Ip有限公司 |
修饰的病毒载体及其制备和使用方法
|
|
JP7389040B2
(ja)
|
2018-01-17 |
2023-11-29 |
メイラジーティーエックス・ユーケー・ザ・セカンド・リミテッド |
遺伝子治療のための修飾ｒＡＡＶキャプシドタンパク質
|
|
GB201800903D0
(en)
|
2018-01-19 |
2018-03-07 |
Oxford Genetics Ltd |
Vectors
|
|
IL325122A
(en)
|
2018-02-22 |
2026-02-01 |
Akouos Inc |
Compositions and methods for treating non-age-related hearing impairment in humans
|
|
CN112424359A
(zh)
|
2018-05-15 |
2021-02-26 |
沃雅戈治疗公司 |
用于治疗帕金森氏病的组合物和方法
|
|
WO2019222329A1
(en)
|
2018-05-15 |
2019-11-21 |
Voyager Therapeutics, Inc. |
Compositions and methods for delivery of aav
|
|
WO2019241486A1
(en)
|
2018-06-13 |
2019-12-19 |
Voyager Therapeutics, Inc. |
Engineered 5' untranslated regions (5' utr) for aav production
|
|
US20210254103A1
(en)
|
2018-07-02 |
2021-08-19 |
Voyager Therapeutics, Inc. |
Treatment of amyotrophic lateral sclerosis and disorders associated with the spinal cord
|
|
WO2020023612A1
(en)
|
2018-07-24 |
2020-01-30 |
Voyager Therapeutics, Inc. |
Systems and methods for producing gene therapy formulations
|
|
US10842885B2
(en)
|
2018-08-20 |
2020-11-24 |
Ucl Business Ltd |
Factor IX encoding nucleotides
|
|
GB201813528D0
(en)
|
2018-08-20 |
2018-10-03 |
Ucl Business Plc |
Factor IX encoding nucleotides
|
|
WO2020053258A1
(en)
|
2018-09-12 |
2020-03-19 |
Uniqure Ip B.V. |
Rnai induced c9orf72 suppression for the treatment of als/ftd
|
|
US20220125073A1
(en)
*
|
2018-09-20 |
2022-04-28 |
Tallgrass Biologics L.L.C. |
Treatment and control of colony collapse disorder
|
|
CN109295172A
(zh)
*
|
2018-09-26 |
2019-02-01 |
浙江海洋大学 |
大黄鱼清道夫受体家族基因的密码子偏好性分析方法
|
|
US12281321B2
(en)
|
2018-09-28 |
2025-04-22 |
Voyager Therapeutics, Inc. |
Frataxin expression constructs having engineered promoters and methods of use thereof
|
|
WO2020072849A1
(en)
|
2018-10-04 |
2020-04-09 |
Voyager Therapeutics, Inc. |
Methods for measuring the titer and potency of viral vector particles
|
|
AU2019354793A1
(en)
|
2018-10-05 |
2021-05-13 |
Voyager Therapeutics, Inc. |
Engineered nucleic acid constructs encoding AAV production proteins
|
|
US20210371470A1
(en)
|
2018-10-12 |
2021-12-02 |
Voyager Therapeutics, Inc. |
Compositions and methods for delivery of aav
|
|
WO2020081490A1
(en)
|
2018-10-15 |
2020-04-23 |
Voyager Therapeutics, Inc. |
EXPRESSION VECTORS FOR LARGE-SCALE PRODUCTION OF rAAV IN THE BACULOVIRUS/Sf9 SYSTEM
|
|
WO2020104480A1
(en)
|
2018-11-19 |
2020-05-28 |
Uniqure Biopharma B.V. |
Adeno-associated virus vectors for expressing fviii mimetics and uses thereof
|
|
WO2020104295A1
(en)
|
2018-11-19 |
2020-05-28 |
Uniqure Ip B.V. |
Rnai induced reduction of ataxin-3 for the treatment of spinocerebellar ataxia type 3
|
|
AU2019382824A1
(en)
|
2018-11-19 |
2021-06-03 |
Uniqure Ip B.V. |
Method and means to deliver miRNA to target cells
|
|
AU2019385638A1
(en)
|
2018-11-19 |
2021-06-03 |
Uniqure Ip B.V. |
A companion diagnostic to monitor the effects of gene therapy
|
|
CA3125770A1
(en)
|
2019-01-18 |
2020-07-23 |
Voyager Therapeutics, Inc. |
Methods and systems for producing aav particles
|
|
US20220243225A1
(en)
|
2019-04-29 |
2022-08-04 |
Voyager Therapeutics, Inc. |
SYSTEMS AND METHODS FOR PRODUCING BACULOVIRAL INFECTED INSECT CELLS (BIICs) IN BIOREACTORS
|
|
SMT202400486T1
(it)
|
2019-07-15 |
2025-01-14 |
Meiragtx Uk Ii Ltd |
Proteine di capside avv modificate per il trattamento della malattia artritica
|
|
EP4010465A1
(en)
|
2019-08-09 |
2022-06-15 |
Voyager Therapeutics, Inc. |
Cell culture medium for use in producing gene therapy products in bioreactors
|
|
EP4022070A1
(en)
|
2019-08-26 |
2022-07-06 |
Voyager Therapeutics, Inc. |
Controlled expression of viral proteins
|
|
WO2021041375A1
(en)
*
|
2019-08-26 |
2021-03-04 |
Rootpath Genomics, Inc. |
Compositions and methods for producing adeno-associated viral vectors
|
|
WO2021053018A1
(en)
|
2019-09-16 |
2021-03-25 |
Uniqure Ip B.V. |
Targeting misspliced transcripts in genetic disorders
|
|
US20230020565A1
(en)
*
|
2019-12-04 |
2023-01-19 |
Sangamo Therapeutics, Inc. |
Novel compositions and methods for producing recombinant aav
|
|
CA3168055A1
(en)
|
2020-02-21 |
2021-08-26 |
Emmanuel John Simons |
Compositions and methods for treating non-age-associated hearing impairment in a human subject
|
|
WO2021195491A2
(en)
*
|
2020-03-26 |
2021-09-30 |
Asklepios Biopharmaceutical, Inc. |
Inducible promoter for viral vector production
|
|
CN115867647A
(zh)
*
|
2020-04-02 |
2023-03-28 |
优尼科生物制药有限公司 |
新型细胞系
|
|
AU2021250656A1
(en)
*
|
2020-04-02 |
2022-09-15 |
Uniqure Biopharma B.V. |
Dual bifunctional vectors for AAV production
|
|
EP4133074A1
(en)
|
2020-04-07 |
2023-02-15 |
uniQure IP B.V. |
Gene constructs for silencing angiopoietin-like 3 (angptl3) and uses thereof
|
|
CA3180222A1
(en)
|
2020-04-15 |
2021-10-21 |
Voyager Therapeutics, Inc. |
Tau binding compounds
|
|
US20230285596A1
(en)
|
2020-07-27 |
2023-09-14 |
Voyager Therapeutics, Inc |
Compositions and methods for the treatment of niemann-pick type c1 disease
|
|
BR112023001456A2
(pt)
|
2020-07-27 |
2023-04-11 |
Voyager Therapeutics Inc |
Composições e métodos para o tratamento de distúrbios neurológicos relacionados à deficiência de beta glicosilceramidase
|
|
EP4192514A1
(en)
|
2020-08-06 |
2023-06-14 |
Voyager Therapeutics, Inc. |
Cell culture medium for use in producing gene therapy products in bioreactors
|
|
WO2022187548A1
(en)
|
2021-03-03 |
2022-09-09 |
Voyager Therapeutics, Inc. |
Controlled expression of viral proteins
|
|
WO2022187473A2
(en)
|
2021-03-03 |
2022-09-09 |
Voyager Therapeutics, Inc. |
Controlled expression of viral proteins
|
|
CN115427561B
(zh)
|
2021-03-09 |
2024-06-04 |
辉大(上海)生物科技有限公司 |
工程化CRISPR/Cas13系统及其用途
|
|
WO2022214635A1
(en)
|
2021-04-08 |
2022-10-13 |
Stichting Vu |
Nucleic acid molecules for compensation of stxbp1 haploinsufficiency and their use in the treatment of stxbp1-related disorders
|
|
CA3220866A1
(en)
|
2021-06-02 |
2022-12-08 |
- Anggakusuma |
Insect cell production of parvoviral vectors with modified capsid proteins
|
|
CA3219847A1
(en)
|
2021-06-02 |
2022-12-08 |
Sander Jan Hendrik Van Deventer |
Adeno-associated virus vectors modified to bind high-density lipoprotein
|
|
JP2024523445A
(ja)
|
2021-06-21 |
2024-06-28 |
ユニキュアー バイオファーマ ビー．ブイ． |
α－シヌクレインをサイレンシングするための遺伝子構築物及びその使用
|
|
WO2022268811A1
(en)
|
2021-06-21 |
2022-12-29 |
Uniqure Biopharma B.V. |
Improved lysis procedures
|
|
WO2023283962A1
(en)
|
2021-07-16 |
2023-01-19 |
Huigene Therapeutics Co., Ltd. |
Modified aav capsid for gene therapy and methods thereof
|
|
US20250084383A1
(en)
*
|
2021-07-28 |
2025-03-13 |
Biomarin Pharmaceutical Inc. |
Large scale adeno-associated virus production systems
|
|
CN117716044A
(zh)
*
|
2021-07-28 |
2024-03-15 |
生物马林药物股份有限公司 |
大规模腺相关病毒生产系统
|
|
US20250297278A1
(en)
|
2021-08-26 |
2025-09-25 |
Uniqure Biopharma B.V. |
Insect cell-produced high potency AAV vectors with CNS-tropism
|
|
US20250049955A1
(en)
|
2021-11-17 |
2025-02-13 |
Voyager Therapeutics, Inc. |
Compositons and methods for the treatment of neurological disorders related to glucosylceramidase beta deficiency
|
|
US20250346920A1
(en)
|
2022-01-25 |
2025-11-13 |
Voyager Therapeutics, Inc. |
Baculovirus expression system
|
|
CN114703203B
(zh)
*
|
2022-02-11 |
2024-08-06 |
上海渤因生物科技有限公司 |
杆状病毒载体及其用途
|
|
EP4508216A1
(en)
|
2022-04-12 |
2025-02-19 |
uniQure biopharma B.V. |
Nucleic acid regulation of snca
|
|
WO2023198702A1
(en)
|
2022-04-12 |
2023-10-19 |
Uniqure Biopharma B.V. |
Nucleic acid regulation of c9orf72
|
|
EP4508215A1
(en)
|
2022-04-12 |
2025-02-19 |
uniQure biopharma B.V. |
Novel systems for nucleic acid regulation
|
|
US20250223590A1
(en)
|
2022-04-12 |
2025-07-10 |
Uniqure Biopharma B.V. |
Nucleic acid regulation of ApoE
|
|
WO2023240236A1
(en)
|
2022-06-10 |
2023-12-14 |
Voyager Therapeutics, Inc. |
Compositions and methods for the treatment of spinal muscular atrophy related disorders
|
|
WO2024054983A1
(en)
|
2022-09-08 |
2024-03-14 |
Voyager Therapeutics, Inc. |
Controlled expression of viral proteins
|
|
WO2024143440A1
(ja)
|
2022-12-28 |
2024-07-04 |
富士フイルム株式会社 |
アデノ随伴ウイルスの製造方法、およびベクターのセット
|
|
AU2023427408A1
(en)
|
2023-02-02 |
2025-09-04 |
Voyager Therapeutics, Inc. |
Compositions and methods for the treatment of neurological disorders related to glucosylceramidase beta deficiency
|
|
EP4698555A1
(en)
|
2023-04-18 |
2026-02-25 |
uniQure biopharma B.V. |
Novel neurotropic adeno-associated virus capsids with detargeting of peripheral organs
|
|
EP4698648A1
(en)
|
2023-04-18 |
2026-02-25 |
uniQure biopharma B.V. |
Gene delivery vehicles comprising rna and antibodies
|
|
WO2024218190A1
(en)
|
2023-04-18 |
2024-10-24 |
Uniqure Biopharma B.V. |
Generation of adeno-associated virus capsid libraries for insect cells
|
|
WO2024226761A2
(en)
|
2023-04-26 |
2024-10-31 |
Voyager Therapeutics, Inc. |
Compositions and methods for treating amyotrophic lateral sclerosis
|
|
EP4731267A1
(en)
|
2023-06-23 |
2026-04-29 |
uniQure biopharma B.V. |
Novel fragile x constructs
|
|
KR20260082361A
(ko)
|
2023-08-31 |
2026-06-04 |
디노 테라퓨틱스, 인코포레이티드 |
캡시드 폴리펩타이드 및 이의 사용 방법
|
|
EP4774387A1
(en)
|
2023-09-04 |
2026-07-15 |
uniQure biopharma B.V. |
Novel neurotropic recombinant adeno-associated virus particles
|
|
CN122319242A
(zh)
|
2023-10-11 |
2026-06-30 |
优尼科生物制药有限公司 |
亨廷顿蛋白基因的新型核酸调节
|
|
CN122341734A
(zh)
|
2023-10-11 |
2026-07-03 |
优尼科生物制药有限公司 |
重复扩增障碍中msh3的核酸调节
|
|
WO2025078606A1
(en)
|
2023-10-11 |
2025-04-17 |
Uniqure Biopharma B.V. |
Further novel systems for nucleic acid regulation
|
|
CN122580434A
(zh)
|
2023-11-30 |
2026-08-14 |
优尼科生物制药有限公司 |
用于病毒药物产品的配制品
|
|
TW202545971A
(zh)
|
2024-02-08 |
2025-12-01 |
美商戴諾治療公司 |
殼體多肽及其使用方法
|
|
WO2025219443A1
(en)
|
2024-04-19 |
2025-10-23 |
Uniqure Biopharma B.V. |
Nucleic acid for a1at regulation
|
|
US20260061079A1
(en)
|
2024-08-22 |
2026-03-05 |
Uniqure Biopharma B.V. |
BBB interacting capsids
|
|
WO2026041782A1
(en)
|
2024-08-22 |
2026-02-26 |
Uniqure Biopharma B.V. |
Novel raav capsids
|
|
WO2026064428A2
(en)
|
2024-09-18 |
2026-03-26 |
Dyno Therapeutics, Inc. |
Capsid polypeptides and methods of use thereof
|
|
WO2026064442A2
(en)
|
2024-09-18 |
2026-03-26 |
Dyno Therapeutics, Inc. |
Capsid polypeptides and methods of use thereof
|
|
WO2026064444A1
(en)
|
2024-09-18 |
2026-03-26 |
Dyno Therapeutics, Inc. |
Capsid polypeptides and methods of use thereof
|
|
WO2026122963A1
(en)
|
2024-12-06 |
2026-06-11 |
Dyno Therapeutics, Inc. |
Capsid polypeptides and methods of use thereof
|